← Leaderboards
Dimiter S Dimitrov
Basic Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesBaseExhibitsMonoclonal AntibodiesStructureLibrariesBinding (Molecular Function)AntigensEngineeringAffinityHuman Monoclonal AntibodiesEpitopesProteinsKillingsAnimalsInfectionVirusPharmaceutical PreparationsDiagnosisPropertyAnimal ModelGlycoproteinsImmune SystemReceptor
Grant awards (36)
Human Monoclonal Antibodies Against Cancer$920,549
ZIA · FY2017 · CA · contact PI
Antibody therapeutics against biodefense-related diseases$306,849
ZIA · FY2017 · CA · contact PI
Antibody-based therapeutics and vaccines against AIDS$306,849
ZIA · FY2017 · CA · contact PI
Human Monoclonal Antibodies Against Cancer$909,717
ZIA · FY2016 · CA · contact PI
Antibody therapeutics against biodefense-related diseases$303,238
ZIA · FY2016 · CA · contact PI
Antibody-based therapeutics and vaccines against AIDS$303,238
ZIA · FY2016 · CA · contact PI
Human Monoclonal Antibodies Against Cancer$746,707
ZIA · FY2015 · CA · contact PI
Antibody therapeutics against biodefense-related diseases$248,903
ZIA · FY2015 · CA · contact PI
Antibody-based therapeutics and vaccines against AIDS$248,903
ZIA · FY2015 · CA · contact PI
Human Monoclonal Antibodies Against Cancer$771,668
ZIA · FY2014 · CA · contact PI
Antibody therapeutics against biodefense-related diseases$257,223
ZIA · FY2014 · CA · contact PI
Antibody-based therapeutics and vaccines against AIDS$257,223
ZIA · FY2014 · CA · contact PI
Human Monoclonal Antibodies Against Cancer$758,299
ZIA · FY2013 · CA · contact PI
Antibody therapeutics against biodefense-related diseases$252,767
ZIA · FY2013 · CA · contact PI
Antibody-based therapeutics and vaccines against AIDS$252,767
ZIA · FY2013 · CA · contact PI
Human Monoclonal Antibodies Against Cancer$830,477
ZIA · FY2012 · CA · contact PI
Antibody-based therapeutics and vaccines against AIDS$276,826
ZIA · FY2012 · CA · contact PI
Antibody therapeutics against biodefense-related diseases$276,826
ZIA · FY2012 · CA · contact PI
Human Monoclonal Antibodies Against Cancer$723,891
ZIA · FY2011 · CA · contact PI
Antibody-based therapeutics and vaccines against AIDS$241,297
ZIA · FY2011 · CA · contact PI
Antibody therapeutics against biodefense-related diseases$241,297
ZIA · FY2011 · CA · contact PI
Human Monoclonal Antibodies Against Cancer$588,464
ZIA · FY2010 · CA · contact PI
Antibody-based therapeutics and vaccines against AIDS$353,078
ZIA · FY2010 · CA · contact PI
Antibody therapeutics against biodefense-related diseases$235,386
ZIA · FY2010 · CA · contact PI
Human Monoclonal Antibodies Against Cancer$649,065
ZIA · FY2009 · CA · contact PI
Antibody-based therapeutics and vaccines against AIDS$389,439
ZIA · FY2009 · CA · contact PI
Antibody therapeutics against biodefense-related diseases$259,626
ZIA · FY2009 · CA · contact PI
Human Monoclonal Antibodies and Antibody-Guided Nanoparticles$1,257,527
Z01 · FY2008 · CA · contact PI
Human Monoclonal Antibodies and Antibody-Guided Nanoparticles$1,350,560
Z01 · FY2007 · CA · contact PI
Systems Biology of Cancer Cells$0
Z01 · FY2003 · BC
HIV-1 Entry$0
Z01 · FY2002 · BC
Cell Dynamics in Cancer and AIDS$0
Z01 · FY2002 · BC
HIV-1 Entry$0
Z01 · FY2001 · BC
Cell Dynamics in Cancer and AIDS$0
Z01 · FY2001 · BC
HIV-1 Entry$0
Z01 · FY2000 · BC
Cell Dynamics in Cancer and AIDS$0
Z01 · FY2000 · BC